Tlw,--..Ul.U.,,.,-_,..«1opla'""'"toth,followltta....,.W.lh>tcom.t aclu!Y<IJWU•*--"'""'""'Edl-ofu,,,.,...,J.>,:,w,,m,,AUA..,.....,,.. Th<SnodrnlSotudyGuid<•Glooouy•Rtf<ff!ICG i'<>dC....prochK,edbj, CNSl'rodu<.oom! .. turinJD r. DorTtJm'lb a AJ6.-graphl<nornl&,s.,.,,,.,10piat<> A«<ootot.belO-pon ... ollilmo,U><• ..U...,""4Addkt!oo- Thor).-ho1ltls.ttm)h<no-llWOO"U Com<toOOrlwrlJoit<:.....,.~tlons .<:om/bene6t a.pt<r1or,.,..,.&.. .. 1...,ll<likdpockat<bj,6llinsinJ'O"< tmail-.,,and.J'OW"pmoc<><krr.-lh,bo1bdo..- . How to Access eResources WhatUan<Ruo un,1 An,Fnourc,i,,11nyadditionalrnourc,tha tacrompanin•n ••l•xtbookwdt u•lttm i1<(Lo.Crngag•Brain ,P,an,on MyLab.,«c.) Hf>WdoyoM,ioc,sson, R...,..,u/ ace," When• bookhu 11naccomp•nying<R<>OUru, you will thathrough th, onlin, Vi!alSourc, Boobhelf' ••t<xtoool platformfollowingth< rl<prl><low: LogintoBoobltdfOnl ine U,ingyoo rmo 0><,dickth0Acooontiron inthetO(>•rightcorner to11CC<Uth<drop•downmrn1.L \\lhen one or more of yoor <•t<xtboob ha,., an •ccompanying ,Fnoo rc,, the R<>OUrc.,m ,no will apr,ar. u., your mom, tordec! the link. Not,: If>"udon'r =ti,, R,wun:<> ,,.,nu. and>"u rhjnk>"u ,J,ould, thrn try«l<eting Too!r>Updat,l.ilm,ry. 4 ThoR,sourcnp•g,willlinof•ny<-tntboobthatha,..acromp:myingma tttialr. To=l! he:icca, code,did the 'Reval Code'. No/,: On« a cod, luu b<m uv,akd, /Ju ,-/,xt!>ool i, no lcngff utumabl<. "'"•led. 5 If• code !tu •lnady bttn the following m<..ag< will be di>play,d 'eR<>oorc, Code, already "'" •led~ Not,: Sd«, Clkkheujo, ;,,,1ruc:ti011,onw ing )"J'l'r<R...,..,u rod<. Physicaal nd Mental Effects of PsychoactivDe rugs EighthE dition Darryl S. Inaba, Pharm.D., CATC-VC, ADC Ill Director of Clinical and BehavioralH ealth Services,A ddictions Recovery Center, Medford, Oregon Director of Research and Education,C NS Productions,I nc., Medford, Oregon AssociateC linical Professor of Pharmacology,U niversityo f California Medical Center, San Francisco Consultant/Instructor, Universityo f Utah, School on Alcoholism and Other Drug Dependencies,S atl Lake City, Utah William E. Cohen, CGACI CNS Productions, Inc.™ Medford, Oregon CNS Productions, Inc.™ Publisher: Paul J. Steinbroner 11 Almond Street Medford, OR 97504 Tel: (800) 888-0617 · Fax: (541) 773-5905 Web Site: www.cnsproductions .com E-mail: [email protected] Uppers, Downers, All Arounders, Eighth Edition © 2014 Darryl S. Inaba First Edition ©1989 Second Edition ©1993 Third Edition ©1997 Fourth Edition ©2000 Fifth Edition ©2004 Sixth Edition ©2007 Seventh Edition ©2011 Editors: Ellen Cholewa and Elizabeth van Radics Book Design and Illustrations: Impact Publications/David Ruppe, Medford, Oregon Cover Design: Don Thomas Illustration , Ashland, Oregon Printing and Color Separations: Cedar Graphics , Cedar Rapids, Iowa Co-writer, Chapter 10: Pablo Stewart , M.O., Clinical Professor of Psychiatry, University of California, San Francisco, School of Medicine Special thanks to: Addictions Recovery Center , Medford, Oregon Hassan Igram, Founder, Cedar Graphics, Cedar Rapids, Iowa Disclaimer: The information in this book is in no way meant to replace professional medical advice or professional counseling and treatment. Publisher's Cataloging-in-Publication Inaba, Darryl S. Uppers, downers, all arounders: physical and mental effects of psychoactive drugs/Darryl S. Inaba, William E. Cohen-8th ed. p.cm. Includes index LCCN: 2014938512 ISBN: 978-0-926544-39-0 Psychoactive drugs-- Side effects. 2. Drug abuse- Complications. I. Cohen, William E., 1941-ll. Title All rights reserved. No part of this book may be reproduced or utilized in any form, electronic or mechanical , including photocopying, recording, storing in any information and retrieval system, or transmitting by any means without prior written permission of the publisher. Printed in the United States of America Uppers, Downers, All Arounders, Eighth Edition, is adoringly dedicated to the creative genius of its co-author, William E. Cohen. Bill was already established as a national Peabody- and Emmy Award-winning video journalist when he teamed up with co-author Dr. Darryl Inaba and producer Paul Steinbroner in the 1970s to create the educational film Psychoactive. Like most professionals who are exposed to the addiction field, Bill became immediately enchanted by the courageous struggle and the miraculous recovery outcomes of those vulnerable to the medical condition now known as substance-related and addictive disorders. Most of all, Bill became fascinated by the evolving science of addiction and recovery. He immediately went from that first film to create the educational booklet by the same name, which was the forerunner of this publication, now in its eighth edition. Bill also became a Certified Gambling Addiction Counselor ( CGAC I) and assisted several hundred individua ls struggling with this condition into recovery many decades before gambling was finally recognized as an addiction by the DSM-5, published in May 2013. As clinicians and educators fall in love with this field, William E. Cohen fell in love with Uppers, Downers, All Arounders and dedicated his entire life to promoting a better understanding of addiction and recovery William E. Cohen November 2, 1941-May 20, 2014 • Key Phrase Highlights Key phrases are in boldface throughout the book to emphasize the most significant concepts and to help the reader prioritize the information . Chapter introductions and reviews, exercises, and most test questions are based on these boldfaced phrases. Study Guide and Glossary A study guide and glossary are available for download from our Web site. More information can be found on the inside front cover of this book. Supplementary Material Visit www.cnsproductions.com for additional content. Dr. lnaba's weekly podcast, video blogs, a reader forum, useful links, and other learning tools are regularly updated and available 24/7. You can access a video clip specific to each chapter using the QR (quick reference) tags found on each chapter's opening page. Data and References Every effort has been made to incorporate the most current and comprehensive information available at the time of publication . Some of the research studies cited are conducted every 2, 5, 10, or in some cases 20 years and are included to illustrate trends or because they provide pertinent information that is not time sensitive. References are cited after significant data presentations by numerical position in each chapter. These are then available for download from our Web site by chapter where the reference was cited. Note: The registered trademark symbol ® distinguishes trade (brand) names of prescription and over-the-counter drugs from chemical (generic) names. Chapter 1 PsychoactiveD rugs: Uppers dassificationandHistory Introduction C..nl!falClassification ::fi";':~~ ionofPsyd,oactiveDrugs General Effects ),fajorDrug< Cocaine OtherDrug,andAddictions Smok>bl,Cocaine(crack .f=ba«,oxidado) Amphetamines ~:i:c:o ~oactiv,, Drugs t:t;.1~:i:~ ~!:'.:counter Stimulants Fh,eHi>toricalTh<meso/DrugU« Miscelbneou,PbntStimubnts Prd>i>toryrndtheNrolithicPeriod (8300-i OOOB.C) uff<ine AncientCiviliz.:otion,(4000B.C. -A.D.100) TheMiddleAg<>(-400 -1100) TheR,nal,..nceandtheAgeofDi,;cov,ry ChapterReview (1+00- 1700) TheAgeofEnlight<nmentandtheUriy Chapter 4 lndu,;lrullR<volution(l700-1900) TheTwenti<thUiltury Downers:O piates/Opioids ~::;;:,,";;,!omorrow and Sedative-Hypnotics Chapte<Review C..nl!falClassification -t.l MajorO.pre,.,,mts i .l MinorD<pT<Ssana Chapter 2 Prescription Drug Epidem ic TheNeurochemistryand ~~i::~ ~o id, the Physiologyo f Addiction Cbmfication i.6 HowP!;yd,oactiv,,DrugsAffectl'eople Hi>toryofMethodsoll'« i.7 HowDrug,G<ttoth<Br>.in Twmti<th andTwmty-Fir>tCenturie, The Nervous System Effect>ofOpioid, Neuroanatomy Thaap,uticPainControlv. .Hyp,ralgesia Phy,iological R«pons«toDrug> Additiona!Complicatioru;C.us«lbyOpioid.s FromExp,rimentationtoAddiction ~~ru1~:"::1ai:;E~~! didion Sp,cificOpioids Theorie,ofAddiction Sedative-Hypnotics Her<dity.Env!ronment,P,ychoactiveDrug, ~:l:cation ~io~~~:;~~"' •~~";'Mice ~!:~\~:! View of th< Addictive Proc<SS Chapte<Review Oth<rSroativ<-Hypnotic, i .il Druglnt<r.tctiom i .+4 PrescriptionDrug,andth<Phnmocrnticallndu,;tryi .+4 ChapterReview • Chapter5 Anticholinergic Psychedelics 5.0 (belladonna , henbane, mandrake, and datura (jimsonweed, thomapple]) 6.20 Downers: Alcohol PCP, Ketamine, Salvia Divinorum, and Overview 5.1 Other Psychedelics 6.21 Introduction 5.1 Marijuana and Other Cannabinoids 6.25 History 5.2 Chapter Review 6.46 AlcoholicB everages 5.5 The Chemistry of Alcohol 5.5 Chapter7 Types of Alcoholic Beverages 5.5 7.0 Absorption,D istribution,a nd Metabolism 5.8 Other Drugs,O ther Addictions Absorption and Distribution 5.8 Metabolism 5.9 Introduction 7.1 Desired Effects,S ide Effects, Other Drugs 7.2 and Health Consequences 5.10 Inhalants 7.2 Levels of Use 5.11 Sports and Drugs 7.11 Low-to-Moderate-Dose Episodes 5.12 Miscellaneous Drugs 7.27 High-Dose Episodes 5.14 Other Addictions 7.30 Chronic High-Dose Use 5.17 Compulsive Behaviors 7.30 Addiction Heredity, Environment , and Compulsive Behaviors 7.31 (alcohol dependence,o r alcoholism) 5.21 Compulsive Gambling 7.33 Classification 5.21 Compulsive Shopping and Buying 7.43 Heredity, Environment, and Psychoactive Drugs 5.23 Hoarding 7.44 Tolerance, Tissue Dependence, and Withdrawal 5.24 Eating Disorders 7.45 Directions in Research 5.26 Sexual Addiction 7.55 Other Problemsw ith Alcohol 5.27 Electronic Addictions 7.57 Polydrug Abuse 5.27 Conclusions 7.61 Alcohol and Mental Problems 5.27 Chapter Review 7.62 Alcohol and Pregnancy 5.28 Aggression and Violence 5.31 Chapter8 Driving Under the Influence 5.33 8.0 Injuries and Suicide 5.35 Epidemiology 5.35 Drug Use and Prevention: Patterns of Alcohol Consumption 5.35 From Cradle to Grave Population Subgroups 5.37 Prevention 8.1 Ethnic Populations 5.42 Concepts of Prevention 8.2 Conclusions 5.44 History 8.3 Chapter Review 5.45 Prevention Methods 8.7 Challenges to Prevention 8.15 Chapter6 6.0 From Cradlet o Grave 8.17 Patterns of Use 8.17 All Arounders Pregnancy and Birth 8.18 Youth and School 8.27 Introductiona nd History 6.1 Love, Sex, and Drugs 8.34 Classification 6.3 Drugs at Work 8.46 General Effects 6.3 Drugs in the Military 8.49 LSD, Psilocybin Mushrooms, and Other Drug Testing 8.50 Indole Psychedelics 6.5 Drugs and the Elderly 8.54 Peyote, MOMA, and Other Phenylalkylamine Conclusions 8.58 Psychedelics 6.13 Chapter Review 8.59 Chapter 9 TargetP opulations 9.54 9.0 Men vs. Women 9.54 Youth 9.54 Treatment Older Americans 9.55 Introduction 9.1 Ethnic Groups 9.57 A Disease of the Brain 9.2 Other Groups 9.61 Current Issues in Treatment 9.2 TreatmentO bstacles 9.62 TreatmentE ffectiveness 9.6 Developmental Arrest and Cognitive Impairments 9.62 Treatment Studies 9.6 Follow-Through (monitoring) 9.63 Drug Abuse Treatment Outcome Study 9.6 Conflicting Goals 9.63 Treatment and Prisons 9.7 Treatment Resources 9.64 Principlesa nd Goalso f Treatment 9.8 Medical InterventionD evelopments 9.64 Principles of Effective Treatment 9.8 Introduction 9.64 Principles of Drug-Abuse Treatment Medications Approved to Treat SUDs for CJS Populations 9.8 vs. Those Used Off-Label 9.64 Goals of Effective Treatment 9.9 Medical Strategies in Development to Treat SUDs 9.66 Selectiono f a Program 9.10 The New Drug Development Process 9.68 Diagnosis 9.10 ChapterR eview 9.69 Treatment Options 9.12 BeginningT reatment 9.14 Chapter 10 10.0 Recognition and Acceptance 9.15 TreatmentC ontinuum 9.18 Mental Health and Drugs Detoxification 9.19 Initial Abstinence 9.20 Introduction 10.1 Long-Term Abstinence 9.20 Determining Factors 10.3 Recovery 9.21 Dual Diagnosis( co-occurringd isorders) 10.5 Relapse Prevention 9.21 Definition 10.5 Relapse Prevention Strategies 9.24 Epidemiology 10.6 Outcome and Follow-Up 9.24 Patterns of Dual Diagnosis 10.7 Individualv s. GroupT herapy 9.25 Making the Diagnosis 10.7 Individual Therapy 9.25 Mental Health vs. Substance Abuse 10.9 Group Therapy 9.26 Psychiatric Disorders: Pre-Existing Treatmenta nd the Family 9.31 Mental Disorders 10.13 Substance-Induced Mental Disorders 10.18 Goals of Family Treatment 9.32 Different Family Approaches 9.32 Treatment 10.21 Other Behaviors 9.33 Psychopharmacology 10.24 Trauma-Informeda nd Trauma-FocusedC are 9.34 ChapterR eview 10.31 RecoveryC oach 9.34 Adjunctivea nd Complementary References R.1 TreatmentS ervices 9.35 Glossary G.1 Drug-SpecificT reatment 9.37 Index 1.1 Polydrug Abuse 9.37 Stimulants (cocaine and amphetamines) 9.37 Tobacco 9.39 Opioids 9.41 Sedative-Hypnotics (barbiturates and benzodiazepines) 9.43 Alcohol 9.44 Psychedelics 9.46 Marijuana 9.46 Inhalants 9.48 Behavioral Addiction Treatment 9.48